MetaCap

SOPHiA GENETICS SA (SOPH)

NASDAQ: SOPHTechnologyEDP ServicesUSD

6.23-0.45 (-6.74%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SOPH stock chart

Technical analysis

Key statistics

All statistics
Market cap
$533.65M
EPS (TTM)
-$1.09
52-week range
4.01 – 8.98
Day range
6.16 – 6.88
Volume / Avg
827.65K / 678.76K
Beta
—

52-week range

$4.01$8.98

SOPH stock today

SOPHiA GENETICS SA (SOPH) closed at $6.23 on Nov 20, down 6.74% (-$0.45), versus the S&P 500's 3.70% decline. At this level, SOPH sits in the middle of its 52-week range of $4.01 to $8.98: 30.6% below the high, set on Aug 27, 2026 and 55.6% above the low. SOPH is up 33.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 37.2%.

SOPHiA GENETICS SA has posted a net loss over the last twelve months (EPS of -$1.09), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About SOPHiA GENETICS SA

Company profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.

Industry
EDP Services
CEO
Mr. Ross Jordan Muken B.Sc.
Headquarters
Rolle
Employees
415
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, SOPHiA GENETICS SA generated $77.3 million in revenue, up 18.6% from fiscal 2024, its 6th consecutive year of revenue growth. SOPHiA GENETICS SA reported a net loss of $79.0 million, compared with a loss of $62.5 million a year earlier. Gross margin was 67.4% (flat year over year) and operating margin -91.8%.

SOPHiA GENETICS SA annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$77.27M$65.17M$62.37M$47.56M$40.45M
Growth+18.56%+4.49%+31.14%+17.58%+42.43%
Net income$-79.00M$-62.49M$-78.98M$-87.45M$-73.67M
EPS (diluted)$-1.17$-0.95$-1.22$-1.36$-1.33

Analyst forecast

Forecast

Consensus (5 analysts)

strong_buy

Avg. price target

$9.75+56.50%

  • Strong buy 0
  • Buy 5
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $7.00High $14.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$-0.30 vs $-0.13
Surprise
-130.77%

SOPH news

All SOPH news

SOPHiA GENETICS SA peers

Technology sector
SOPH peer companies
CompanyPrice% ChgMarket capCompare
TLSTelos Corporation7.26-3.84%$533.85Mvs SOPH
PAYSPaysign Inc.9.80-2.63%$556.89Mvs SOPH
HQHorizon Quantum Holdings Ltd. Class A8.94-6.19%$487.73Mvs SOPH
GRVYGRAVITY Co. Ltd. American Depository Shares69.90-3.88%$485.73Mvs SOPH
OOMAOoma Inc.16.90-0.65%$466.44Mvs SOPH
NRDSNerdWallet Inc. Class A7.14+1.71%$452.65Mvs SOPH
CARSCars.com Inc.12.31-0.24%$641.05Mvs SOPH
SHAZSharonAI Holdings Inc. Class A16.83-18.06%$647.59Mvs SOPH

Indexes, lists and sector

SOPHiA GENETICS SA stock FAQ

What is SOPHiA GENETICS SA's stock price today?

SOPH last traded at $6.23 as of Nov 20, 4:00 PM EST, down 6.74% on the day. Prices are delayed at least 15 minutes.

Who is SOPHiA GENETICS SA's CEO?

Mr. Ross Jordan Muken B.Sc. is the chief executive officer of SOPHiA GENETICS SA, which has about 415 employees.

What is the SOPH 52-week high?

The 52-week high for SOPH is $8.98 and the 52-week low is $4.01. The stock is currently 30.6% below its high.

Compare SOPH